期刊文献+

胰高血糖素样肽-1类似物(JC003)对糖尿病大鼠血糖及胰岛功能的影响 被引量:3

Effects of GLP-1 analog(JC003) on blood glucose and pancreatic functions of diabetes mellitus in rats
下载PDF
导出
摘要 目的探讨胰高血糖素样肽-1类似物(JC003)对实验性糖尿病血糖和胰岛功能的影响。方法84只Wistar大鼠,采用高脂饮食和注射40 mg/kg链脲佐菌素(STZ)方法建立实验性糖尿病动物模型。JC003治疗14 d后,采用酶化学方法检测空腹血糖;采用放射免疫方法检测血清胰岛素和C肽。胰腺组织切片HE染色和链霉菌抗生物素-过氧化物酶(SABC)免疫组化染色方法对胰岛结构和胰岛素表达情况进行观察。结果JC003中剂量组(10μg/kg)、高剂量组(100μg/kg)与糖尿病模型组比较血糖明显降低(P<0.01);中剂量组(10μg/kg)、高剂量组(100μg/kg)的血清胰岛素和C肽水平明显高于糖尿病模型组(P<0.05);JC003各剂量组对糖尿病大鼠的胰岛组织结构有显著的保护作用,并且可以增加胰岛素表达阳性的β细胞(P<0.01)。结论JC003可以通过保护大鼠胰岛细胞免受STZ的伤害和增加胰岛β细胞数量来增加胰岛素的表达和分泌,从而降低糖尿病动物血糖。 Objective To investigate the therapeutic effects of glucagon-like peptide-1 analog (JC003) on blood glucose and pancreatic functions of diabetes mellitus in rats. Methods A total of 84 Wistar rats were used in this experiment. Diabetes mellitus animal models were induced with high-fat diet and injection of 40 mg/kg streptozotociul (STZ). After 14 d of JC003 therapy, the level of fasting plasma glucose (FPG) was detected with enzyme-chemical method. The level of serum insulin and C-peptide were measured with immunoradiometric assay method. Serial pancreatic sections were made and stained with hematoxylin-eosin (HE) and streptavidin-biotin- peroxidase complex (SABC). Results After 14 d of JC003 injection, the level of FPG in medium-dose group (10 μg/kg) and high-dose group (100μg/kg) was lower than that in diabetes mellitus (DM) group (P〈0.01). The level of serum insulin and C-peptide of medium-dose group (10μg/kg) and high-dose group (100μg/kg) was higher than in DM group (P 〈 0. 05). JC003 could protect pancreatic islet from injury of STZ and increase insulin- expressing positive rate (P〈0.01). Conclusion GLP-1 analog (JC003) can lower the level of blood glucose of diabetes mellitus through protecting pancreatic islet β cells and increasing insulin expression and secretion.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第6期651-654,671,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 吉林省科技发展重点基金资助项目(20050413-4) 高等学校博士点基金资助项目(2005)
关键词 胰高血糖素样肽-1 糖尿病 胰岛素 C肽 Β细胞 免疫组织化学 大鼠 glucagon-like peptide- 1 diabetes mellitus insulin C-peptide β cell immunohistochemistry rat
  • 相关文献

参考文献5

  • 1Gautier JF, Fetita S, Sobngwi E, et al. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes [J]. Diabetes Metab, 2005, 31(3pt1): 233- 242.
  • 2Kluz J, Adamiec R. New therapeutic approach in patients with type 2 diabetes based on glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP) [J]. Postepy Hig Med Dosw,2006, 60:15-23.
  • 3刘青,杨翰仪.治疗2型糖尿病新药胰高血糖素样肽-1的研究进展[J].白求恩医科大学学报,2001,27(1):103-104. 被引量:5
  • 4施秉银.胰岛干细胞的研究现状与展望[J].西安交通大学学报(医学版),2005,26(5):409-412. 被引量:4
  • 5Schirra J, Katschinski M, Weidmann C, et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans [J] . J Clin Invest, 1996, 97:92-103.

二级参考文献24

  • 1RenQingFENG LiYingDU ZhenQuanGUO.In vitro cultivation and differentiation of fetal liver stem cells from mice[J].Cell Research,2005,15(5):401-405. 被引量:9
  • 2[1]Mojsov S,Heinrich G,Wilson IB,et al.Preproglucagon gene expression in pancreas and intestine diversifies at the level of posttranscriptional processing[J].J Biol Chem,1986,261:11880-11889.
  • 3[2]Bell GI,Santerre RF,Mullenbach GT.Hamster preproglucagon contains the sequence of glucagon and two related peptides[J].Nature,1983,302:716-718.
  • 4[3]Herrmaan C,Goke R,Richter G,et al.Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients[J].Digestion,1995,56:117-126.
  • 5[4]Schirra J,Katschinski M,Weidmann C,et al.Gastric emptying and releasing of incretin hormones after glucose ingestion in humans.[J].J Clin Invest,1996,97:92-103.
  • 6[5]Brubaker PL.Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides[J].Endocrinology,1991,128:3175-3182.
  • 7[6]Reberge JN,Brubaker PL.Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop[J].Endocrinology,1993,133(1):233-240.
  • 8[7]Nauck MA,Heimesaat MM,Orskov C,et al.Preserved incretin activity of glucagon-like peptide 1(7~36 amide)but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus[J].J Clin Invest,1993,91:301-307.
  • 9[8]Deacon CF,Nauck MA,Nielsen MT,et al.Both subcutaneously and intravenously administered glucagon-like peptide-1 are rapidly degraded from the amino terminus in type Ⅱ diabetic patients and in health subjects[J].Diabetes,1995,44:1126-1131.
  • 10[9]Hupe-Sodmann K,McGregor GP,Bribenbaugh R,et al.Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1 (7~36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides[J].Regul Pept,1995,58:149-156.

共引文献7

同被引文献51

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部